Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women

Journal of Endocrinology

Volumn 199, Issue 1, 2008, Pages 51-60

  Meyers, Julie A ^b   Liu, Amy Y ^a,b   McTiernan, Anne ^a,b   Wener, Mark H ^b   Wood, Brent ^b   Weigle, David S ^b,c   Sorensen, Bess ^a   Chen Levy, Zehava ^b   Yasui, Yutaka ^d   Boynton, Alanna ^a,b   Potter, John D ^a,b   Ulrich, Cornelia M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD3 ANTIBODY; INTERLEUKIN 6; LEPTIN; PHYTOHEMAGGLUTININ; SERUM AMYLOID A;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEPHELOMETRY; OBESITY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; T LYMPHOCYTE SUBPOPULATION;

AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; KILLER CELLS, NATURAL; LEPTIN; LINEAR MODELS; MIDDLE AGED; MITOGENS; NEPHELOMETRY AND TURBIDIMETRY; OBESITY; OVERWEIGHT; PHYTOHEMAGGLUTININS; POSTMENOPAUSE; RADIOIMMUNOASSAY; SERUM AMYLOID A PROTEIN; T-LYMPHOCYTES;

EID: 55049094327     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-07-0569     Document Type: Article

References (44)

1. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, Illingworth JM, Perren TJ, Selby PJ & Whicher JT 1995 The acute phase protein response in patients receiving subcutaneous IL-6. Clinical and Experimental Immunology 102 217-223.
2. Bastard JP, Jardel C, Delattne J, Hainque B, Bruckert E & Oberlin F 1999 Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 2221-2222.
3. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H & Hainque B 2000 Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. Journal of Clinical Endocrinology and Metabolism 85 3338-3342.
4. Bruun JM, Pedersen SB, Kristensen K & Richelsen B 2002 Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Molecular and Cellular Endocrinology 190 91-99.
5. Buettner R, Bollheimer LC, Zietz B, Drobnik W, Lackner K, Schmitz G, Scholmerich J & Palitzsch KD 2002 Definition and characterization of relative hypo- and hyperleptinemia in a large Caucasian population. Journal of Endocrinology 175 745-756.
6. Bullo M, Garcia-Lorda P, Megias I & Salas-Salvado, J 2003 Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obesity Research 11 525-531.
7. Chair A, Han C, Oram J & Heinecke J 2005 Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? Journal of Lipid Research 46 389-403.
8. Chandra R 2002 Nutrition and the immune system from birth to old age. European Journal of Clinical Nutrition 56 S73-S76.
9. Czarkowska-Paczek B, Bartlomiejczyk I, Gabrys T, Przybylski J, Nowak M & Paczek L 2005 Lack of relationship between interleukin-6 and CRP levels in healthy male athletes. Immunology Letters 99 136-140.
10. van Dielen FM, van't Veer C, Schols AM, Soeters PB, Buurman WA & Greve JW 2001 Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. International Journal of Obesity and Related Metabolic Disorders 25 1759-1766.
11. Dovio A, Caramello V, Masera R, Sartori M, Saba L, Tinivella M, Prolo P Termine A, Avagnina P & Angeli A 2004 Natural killer cell activity and sensitivity to positive and negative modulation in uncomplicated obese subjects: relationships to leptin and diet composition. International Journal of Obesity and Related Metabolic Disorders 28 894-901.
12. Farooqi IS, Matarese G, Lord GM, Keogh JM, Lawrence E, Agwu C, Sanna V, Jebb SA, Perna F, Fontana S et al. 2002 Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/ metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation 110 1093-1103.
13. Flegal KM, Carroll MD, Ogden CL & Johnson CL 2002 Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 288 1723-1727.
14. Friedman JM & Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395 763-770.
15. Gainsford T, Willson TA, Metcalf D, Handman E, McFarlane C, Ng A, Nicola NA, Alexander WS & Hilton DJ 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. PNAS 93 14564-14568.
16. Gallistl S, Sudi KM, Aigner R & Borkenstein M 2001 Changes in serum interleukin-6 concentrations in obese children and adolescents during a weight reduction program. International Journal of Obesity and Related Metabolic Disorders 25 1640-1643.
17. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI & Bloom SR 1999 Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. Journal of Clinical Investigation 104 1051-1059.
18. Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L & Casteilla L 2000 Regulation by cytokines of leptin expression in human bone marrow adipocytes. Hormone and Metabolic Research 32 381-385.
19. Lesourd B & Mazari L 1999 Nutrition and immunity in the elderly. Proceedings of the Nutrition Society 58 685-695.
20. Li Z, Lin H, Yang S & Diehl AM 2002 Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. Gastroenterology 123 1304-1310.
21. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR & Lechler RI 1998 Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 897-901.
22. Lord GM, Matarese G, Howard JK, Bloom SR & Lechler RI 2002 Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. Journal of Leukocyte Biology 72 330-338.
23. Manco M, Fernandez-Real JM, Equitani E Vendrell J, Valera Mora ME, Nanni G, Tondolo V, Calvani M, Ricart W, Castagneto M et al. 2007 Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. Journal of Clinical Endocrinology and Metabolism 92 483-490.
24. Marti A, Berraondo B & Martinez JA 1999 Leptin: physiological actions. Journal of Physiology and Biochemistry 55 43-49.
25. Marti A, Marcos A & Martinez JA 2001 Obesity and immune function relationships. Obesity Reviews 2 131-140.
26. Matarese G, Sanna V, Di Giacomo A, Lord GM, Howard JK, Bloom SR, Lechler RI, Fontana S & Zappacosta S 2001 Leprin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. European Journal of Immunology 31 1324-1332.
27. Matarese G, Moschos S & Mantzoros CS 2005 Leptin in immunology. Journal of Immunology 174 3137-3142.
28. McTiernan A, Ulrich CM, Yancey D, Slate S, Nakamura H, Oestreicher N, Bowen D, Yasui Y, Potter J & Schwartz R 1999 The Physical Activity for Total Health (PATH) Study: rationale and design. Medicine and Science in Sports and Exercise 31 1307-1312.
29. Meyers J, McTiernan A & Ulrich C 2005 Leptin and immune function: integraung the evidence. Nutrition Research 25 791-803.
30. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S & Coppack SW 1997 Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.Journal of Clinical Endocrinology and Metabolism 82 4196-4200.
31. Motivala SJ, Dang J, Obradovic T, Meadows GG, Butch AW & Irwin MR, 2003 Leptin and cellular and innate immunity in abstinent alcoholics and controls. Alcoholism, Clinical and Experimental Research 27 1819-1824.
32. Otero M, Lago R, Lago E Casanueva FF, Dieguez C, Gomez-Reino JJ & Gualillo O 2005 Leptin, from fat to inflammation: old questions and new insights. FEBS Letters 579 295-301.
33. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL et al. 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals fiom the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 499-511.
34. Peelman F, Waelput W, Iserentant H, Lavens D, Eyckerman S, Zabeau L & Tavernier J 2004 Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Progress in Lipid Research 43 283-301.
35. Saijo Y, Kiyota N, Kawasaki Y, Miyazaki Y, Kashimura J, Fukuda M & Kishi R 2004 Relationship between C-reactive protein and visceral adipose tissue in healthyJapanese subjects. Diabetes, Obesity and Metabolism 6 249-258.
36. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S & Matarese G 2003 Leptin surge precedes onset of autommune encephalomyelitis and correlates with development of pathogenic T cell responses. Journal of Clinical Investigation 111 241-250.
37. Shade ED, Ulrich CM, Wener MH, Wood B, Yasui Y, Lacroix K, Potter JD & McTiernan A 2004 Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. Journal of the American Dietetic Association 104 903-912.
38. Shamsuzzaman A, Winnicki M, Wolk R, Svatikova A, Phillips B, Davison D, Berger P & Somers V 2004 Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 109 2181-2185.
39. Siegmund B, Lear-Kaul KC, Faggioni R & Fantuzzi G 2002 Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. European Journal of Immunology 32 552-560.
40. Tian Z, Sun R, Wei H & Gao B 2002 Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochemical and Biophysical Research Communications 298 297-302.
41. Vicennati V, Vottero, A, Friedman C & Papanicolaou DA 2002 Hormonal regulation ofinterleukin-6 production in human adipocytes. International Journal of Obesity and Related Metabolic Disorders 26 905-911.
42. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, Bidlingmaier M, Wu Z, Ajami A, Weetman AP, Strasburger CJ & Ross RJ 2001 High-dose leptin activates human leukocytes via receptor expression on monocytes. Journal of Immunology 167 4593-4599.
43. Zeger SL & Liang KY 1986 Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 121-130.
44. Zhao Y, Sun R, You L, Gao C & Tian Z 2003 Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochemical and Biophysical Research Communications 300 247-252.